Cytokines play a prominent role in etiology and pathogenesis of rheumatoid arthritis (RA), and one of these cytokines is interleukin-1β (IL-1β). The association between IL1B gene single nucleotide polymorphism (SNP: rs16944) and rheumatoid arthritis (RA) in a sample of Iraqi patients was investigated. Fifty-one RA patients (21 males and 30 females) were enrolled and their age range was 20 -63 years (44.9 ± 1.5 years). In addition to patients, 45 apparently healthy control subjects were also enrolled in the study. They matched patients for ethnicity (Iraqis), gender (14 males and 31 females) and age (41.3 ± 1.3 years). Analysis of Hardy-Weinberg equilibrium (HWE) in RA patients and controls revealed that the IL1B genotypes were consistent with the equilibrium, and no significant differences (p > 0.05) were observed between the observed and expected genotype frequencies. Inspecting IL1B genotype and allele frequencies in RA patients and controls revealed that there were no significant variations between these frequencies, although a decreased frequency of T allele (67.7 vs. 73.3%) and an increased frequency of C allele (32.3vs. 26.7%) were observed in patients compared to controls. In conclusion, the results are in favor of no association between IL1B gene SNP (rs16944) and RA in Iraqi population.
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Introduction
Rheumatoid arthritis (RA) is a worldwide disease with a global prevalence of 0.24% as based on the Global Burden of Disease in 2010, while among Eastern Mediterranean populations; it has been estimated to be 0.37% [1] . It is a chronic inflammatory autoimmune disease characterized by joint swelling, joint tenderness, and destruction of synovial joints, leading to severe disability and premature mortality [2] . Etiologically, the cause of RA is unknown, but substantial evidence suggests that the disease develops in individuals after interaction between inherited genetic risk factors and environmental triggers. Such interaction can lead to immune dysregulations that are identified as autoantibodies and disturbance of cytokines in serum many years prior to the diagnosis of disease [3] . Accordingly, cytokines have been suggested to play a prominent role in the etiology and pathogenesis of RA, and one of these cytokines is interleukin-1β (IL-1β) [4] .
IL-1β belongs to the IL-1 family, which consists of three further interleukins (IL-1α, IL-18, and IL-33). Expression of IL-1α occurs on the surface of the same cell or retains within the cell, while biological actions of IL-1β is produced by acting on other cells [5] . The action of both interleukins can be blocked by an endogenous inhibitor, which is IL-1 receptor antagonist (IL-1Ra). Both types of IL-1 (IL-1α and IL-1β) exert their activity by binding and signaling through two types of cellular receptors; IL-1RI and IL-1RII. The binding of IL-1 to the former receptor results in intracellular signal transduction, while the latter receptor functions as a decoy receptor for IL-1 [6] .
In RA patients, IL-1β showed a significant increased level in serum and synovial fluid; and moreover, such increase was positively correlated with the disease severity [7] . A further effect of such cytokine was reported on the capacity of synovial fibroblast to produce cytokines, chemokines, and prostaglandins. In addition, IL-1β can activate osteoclast, and in RA patients, such activation was associated with increased expression of endothelial cell adhesion molecules, and the resulting effects lead to an imbalance in bone metabolism that favors bone resorption and osteoporosis [8] . These observations suggest a role for IL-1 in the pathogenesis of RA.
Genetic studies that were based on single nucleotide polymorphisms (SNPs) of IL1 genes revealed that genetic polymorphisms of IL1A, IL1B, and IL1RN genes may have a role in susceptibility to RA. Among these is ILA gene polymorphism at positions -899 (C/T) and +4845 (G/T), which showed positive associations with RA (i.e. increased the risk to develop the disease), and moreover, they were associated with altered serum levels of IL-1. Two IL1B gene SNPs (-511 C/T and +3953 C/T) were also associated with an increased risk of RA and impacted the disease activity and IL-1β expression [9] . In Indian patients, the IL1B -511 C allele was reported to have a protective effect against RA development, and in addition, the results suggested a possible role of IL1B +3953 CT genotype in the severity of RA [10] . However, these findings were subjected to the effect of the ethnicity of RA patients. Such subject has been inspected by a study that was based on a meta-analysis of 16 published association studies of IL1A, IL1B and IL1RN gene polymorphisms in RA. For IL1B -511 SNP (C/T), a negative association between T allele and RA was reported in Caucasian patients, while in Asian RA patients, no such association was observed. However, the TT+TC genotype of IL1B -3953 SNP (C/T) showed a positive association between Caucasian and Asian RA patients [11] . In Tunisian RA patients, IL1B -511 SNP (C/T) was suggested to be associated with susceptibility and severity of disease [12] .
The present study aimed to evaluate the association between a SNP in IL1B gene (T/C: rs16944) and RA among Iraqi patients.
Materials and Methods Patients
The study was approved by the Ethics Committee at the Iraqi Ministry of Health, in which 51 Iraqi RA patients (21 males and 30 females) were enrolled and their age range was 20 -63 years (44.9 ± 1.5 years). They were referred to the Rheumatology Clinic (Baghdad Teaching Hospital) during November 2015 -June 2016 for diagnosis and treatment. The diagnosis was made by the consultant medical staff at the Rheumatology Unit, and it was based on the revised diagnostic criteria established by the American College of Rheumatology (ACR), 2010 [13] . In addition to patients, 45 apparently healthy controls were also enrolled in the study. They matched patients for ethnicity (Iraqis), gender (14 males and 31 females) and age (41.3 ± 1.3 years).
Methods
The Genomic DNA was extracted from EDTA blood using ReliaPrepTM Blood gDNA Miniprep System (Promega Corporation, USA), and after assessing purity and concentration, it was subjected to PCR amplification. Two primers were designed (Forward: 5'-TTCCAGCCTTCTTTGTTTTGTCTC-3' and Reverse: 5'-TCCTCCTCTCTGAGCTTTCTACTC-3') for genotyping of IL1B gene SNP (T/C: rs16944) by using Geneious software version 10.1.3. The PCR reaction was performed in a final volume of 25 µl; which included 12.5 µl GoTaq green Master mix, 0.75 μl forward primer (10 μM), 0.75 μl reverse primer (10 μM), 2 µl DNA sample (50 ng) and 9 µl nuclease-free distilled water. The PCR conditions were initial denaturation at 95°C for 5 minutes (1 cycle), followed by 35 cycles of denaturation at 95°C (30 seconds), annealing at 60°C (30 seconds) and extension at 72°C (30 seconds), followed by a final extension at 72°C for 7 minutes. The amplified PCR fragments were sent for Sanger sequencing using ABI3730XL automated DNA sequencer (Macrogen CorporationKorea). The genotypes were revealed by Geneious software after alignment with a reference sequence in the Gene Bank.
Statistical analysis
Allele and genotype frequencies were given as percentage frequencies. The genotype frequencies were first tested for their agreement with Hardy-Weinberg equilibrium (HWE), and a significant difference between the observed and expected genotype frequencies was assessed by Pearson's Chisquare test (https://www.easycalculation.com/health/hardy-weinberg-equilibrium-calculator.php). The association between IL1B gene SNP (T/C: rs16944) and RA was presented in terms of odds ratio (OR), etiological fraction (EF) and preventive fraction (EF), and a significant difference was assessed by two-tailed Fisher exact probability [14] . The software WinPepi version 11.65 was used to carry out the latter calculations.
Results
Agarose gel electrophoresis of the IL1B gene PCR amplified products (SNP rs16944) showed a single a band of 434bp molecular size, as shown in Figure- The SNP rs16944 (T/C; Chromosome 2: region 112,836,790-112,837,790bp) was presented with three genotypes (TT, TC and CC) and two alleles (T and C) (Figure-2) . Analysis of Hardy-Weinberg equilibrium (HWE) in RA patients and controls revealed that the genotypes were consistent with the equilibrium, and no significant differences (p > 0.05) were observed between the observed and expected genotype frequencies (Table-1 Inspecting IL1B genotype and allele frequencies in RA patients and controls revealed that there were no significant variations between these frequencies, although a decreased frequency of T allele (67.7 vs. 73.3%) and an increased frequency of C allele (32.3vs. 26.7%) were observed in patients compared to controls (Table-2 
Discussion
Inspecting rs16944 SNP (T/C) of IL1B gene in RA patients and controls revealed no significant difference in the distribution of genotype and allele frequencies, although a decreased frequency of T allele and an increased frequency of C allele were observed in patients. Such SNP has been investigated by other studies in RA patients, but inconsistent observations have been made. Bax et al. [9] reported that IL1B gene SNP (-511 T/C) was associated with an increased risk of RA, and such SNP was also associated with disease activity and expression of IL-1β. In contrast, the IL1B -511 C allele was reported to have a protective effect against RA development in Indian patients [10] . These different observation might be related to the ethnicity of RA patients. Such subject has been inspected by a study that was based on a meta-analysis of 16 published association studies of IL1B gene polymorphisms in RA. A negative association between IL1B -511 T allele and RA was reported in Caucasian patients, while in Asian RA patients, no such association was observed [11] . In Tunisian RA patients, IL1B -511 SNP (T/C) was suggested to be associated with susceptibility and severity of disease [12] . More recently, the SNP IL1B -511 showed a significant association with chronic periodontitis and RA in Mexican patients [15] . In conclusion, the results are in favor of no association between IL1B gene SNP (rs16944) and RA in Iraqi population.
